jump to content  sitemap
Division of Division of Pulmonary, Allergy, Critical Care & Sleep Medicine : Department of Internal Medicine : College of Medicine : The Ohio State University
http://internalmedicine.osu.edu/cardiovascular//pulmonary/7095.cfm

 
Tim Eubank
:: Directory ::
Faculty
Fellows - Allergy/Immunology
Fellows - Pulmonary/Critical Care
Fellows - Sleep
Administration
Clinical Programs / PCRM
Clinical Research Trials
Post-Doctoral Researchers
Pre-Doctoral Fellows
Pulmonary / Allergy Outpatient Clinics
Research Scientists
Chris Baran
Jonathan Butchar
Tim Eubank
Mikhail Gavrilin
Virginia Nivar
Anasuya Sarkar

 

Tim Eubank, Ph.D.

Research Scientist

 

201 Davis Heart & Lung Research Institute

473 West 12th Avenue

Columbus, OH 43210

(614) 366-1332
 
Education:
2003     Ph.D.     The Ohio State Biochemistry Program, The Ohio State University
 
Mentor: Clay B. Marsh, MD
 
Research Interests:
Mechanisms of breast cancer growth and metastases
 
Awards and Honors:
2007  Outstanding Poster, Faculty/Research Scientist Division, 2nd Annual Pulmonary Research Day
2006  Chief Post-doctoral Fellow, the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine
2005  Davis Heart & Lung Research Institute Distinguished Post-Doctoral Researcher of the Year
 

Grant Awards:

Current:   NIH/NCI 1 K99 CA131552-01
K99/R00 Pathway to Independence       Role:   PI
Current:   NIH/NCI 1R21CA132068-01         Role:  Co-I
Completed:   OSU DHLRI Internal Funding        Role:  PI
Completed:   NIH/NHLBI T32 HL07946-01 Wewers (PI)       Role:  Fellow

Publications:
1. Eubank TD and Roberts RD, Khan M, Curry JM, Nuovo GJ, Kuppusamy P, and Marsh CB. GM-CSF inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Research. 2008 (In press).
2. Hunter M, Wang Y, Eubank TD, Baran CP, Nan-Sinkham P, Marsh CB. Myeloid Cell Survival and its Role in Health and Disease. Frontiers in Bioscience. 2008 (In press).
3. Curry JM and Eubank TD, Roberts RD, Wang Y, Pore N, Maity A, Marsh CB. M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE. 2008 (In press).
4. Bringardner BD, Baran CP, Eubank TD, Marsh CB. The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis. Antioxid Redox Signal. 2007 Volume 10, Number 2.
5. Parinandi NL, Sharma A, Eubank TD, Kaufman BF, Kutala VK, Marsh CB, Ignarro LJ, Kuppusamy P. Nitroaspirin (NCX-4016), an NO Donor, ia Antiangiogenic Through Induction of Loss of Redox-Dependant Viability and Cytoskeletal Reorganization in Endothelial Cells. Antioxid Redox Signal. 2007 Aug 30.
6. Wang Y, Zeigler MM, Lam GK, Hunter MG, Eubank TD, Khramtsov VV, Tridandapani S, Sen CK, Marsh CB. The Role of the NADPH Oxidase Complex, p38 MAPK and Akt in Regulating Human Monocyte/Macrophage Survival. Am J Respir Cell Mol Biol. 2007 Jan;36(1):68-77.
7. Yang EV, Sood AK, Chen M, Yeh P, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Glaser R. Norepinephrine up-regulates the expression of VEGF, MMP-2 and MMP-9 in nasopharyngeal carcinoma tumor cells. 2006. Cancer Research, Nov 1;66(21):10357-64.
8. Eubank TD, Roberts R, Galloway M, Wang Y, Cohn DE, Marsh CB. GM-CSF Induces Expression ofSoluble VEGF Receptor-1 from Human Monocytes and Inhibits Angiogenesis in Mice. 2004. Immunity, 21:831-842.
9. Eubank TD, Galloway M, Montague CM, Waldman WJ, Marsh CB. M-CSF induces vascular endothelialgrowth factor production and angiogenic activity from human monocytes. 2003. The Journal of Immunology, 171: 2637-2643.
10. Eubank TD, Biswas R, Jovanovic M, Litovchick A, Lapidot A, Gopalan V. Inhibition of bacterial RNase Pby aminoglycoside-arginine conjugates. 2002. FEBS Letters, 511: 107-12.

 


Department of Internal Medicine http://www.internalmedicine.osu.edu
US News and World Report Best Hospitals 2007

The Ohio State University | College of Medicine
Department of Internal Medicine
Division of Pulmonary, Allergy, Critical Care & Sleep Medicine
201 DHLRI | 473 W. 12th Avenue | Columbus, OH 43210
Ph: 614.293.4925 | Contact Us